Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Claassen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
British Journal of Clinical Pharmacology|January 1, 1983
Review of the animal pharmacology and pharmacokinetics of fluvoxamineV Claassen
European Journal of Pharmacology|April 24, 1981
Secoverine selectively antagonizes muscarinic effects in various in vivo preparationsJ M Zwagemakers, V Claassen
Arzneimittel-Forschung|January 1, 1980
Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 1: Antimuscarinic and spasmolytic effectsJ M Zwagemakers, V Claassen
Arzneimittel-Forschung|January 1, 1980
Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological propertiesJ M Zwagemakers, V Claassen
Acta Endocrinologica|July 1, 1971
Influence of dydrogesterone (6-dehydroretroprogesterone, Duphaston) on ovulation in the rat, rabbit and monkeyV Claassen, L Morsink, A M de Wachter
British Journal of Pharmacology|August 1, 1977
Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitorV Claassen, J E Davies, G Hertting, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|June 1, 1973
Differentiation between effects of nicotine and DMPP by amantadineB A Spilker, K M Dhasmana, J E Davies, et al.
Arzneimittel-Forschung|January 1, 1978
Pharmacology of clovoxamine, a new non-tricyclic antidepressantV Claassen, T A Boschman, K M Dhasmana, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
British Journal of Clinical Pharmacology|January 1, 1983
Review of the animal pharmacology and pharmacokinetics of fluvoxamineV Claassen
European Journal of Pharmacology|April 24, 1981
Secoverine selectively antagonizes muscarinic effects in various in vivo preparationsJ M Zwagemakers, V Claassen
Arzneimittel-Forschung|January 1, 1980
Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 1: Antimuscarinic and spasmolytic effectsJ M Zwagemakers, V Claassen
Arzneimittel-Forschung|January 1, 1980
Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological propertiesJ M Zwagemakers, V Claassen
Acta Endocrinologica|July 1, 1971
Influence of dydrogesterone (6-dehydroretroprogesterone, Duphaston) on ovulation in the rat, rabbit and monkeyV Claassen, L Morsink, A M de Wachter
British Journal of Pharmacology|August 1, 1977
Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitorV Claassen, J E Davies, G Hertting, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|June 1, 1973
Differentiation between effects of nicotine and DMPP by amantadineB A Spilker, K M Dhasmana, J E Davies, et al.
Arzneimittel-Forschung|January 1, 1978
Pharmacology of clovoxamine, a new non-tricyclic antidepressantV Claassen, T A Boschman, K M Dhasmana, et al.
Pageof 1